Search

Victor V Gogolak

from McLean, VA
Age ~82
Get Report
Also known as:
Victor J Gogolak, Victor V Gogla, Vic V Gogolak, Victor K
Phone and address:
934 Douglass Dr, Mc Lean, VA 22101
(703) 356-7915
Related to:
Florence V GogolakLeonora R Snyder, 47Christopher R Cote, 55Elise Gogolak Lara, 45Adam M Gogolak, 48Patricia R Gogolak, 81Tanya G Cote, 51Lara E Gogolak, 44
Connected to:
Stephen S Gogolak, 43Agata M Gogolewska, 53Doreen G Gogolewski, 86Luanne R Gogolin, 84Sean A Gogolin, 31Angelika Gogolitsyna, 63Timothy B Gogolla, 45Marius S Gogosanu, 55Stefan G Gogov, 36Mehul Gogri, 37

Victor Gogolak Phones & Addresses

  • 934 Douglass Dr, McLean, VA 22101 (703) 356-7915
  • Mc Lean, VA
  • 934 Douglass Dr, Mc Lean, VA 22101 (703) 999-6546

Work

Company: Booz allen hamilton 1987 to 1999 Position: Partner

Education

Degree: Graduate or professional degree

Skills

Strategic Planning • Start Ups • Pharmaceutical Industry • Business Strategy

Industries

Management Consulting

Resumes

Resumes

Victor Gogolak Photo 1

President And Chief Executive Officer

View page
Location:
Washington, DC
Industry:
Management Consulting
Work:
Booz Allen Hamilton 1987 - 1999
Partner
Druglogic 1987 - 1999
President and Chief Executive Officer
Skills:
Strategic Planning
Start Ups
Pharmaceutical Industry
Business Strategy

Business Records

Name / Title
Company / Classification
Phones & Addresses
Victor V. Gogolak
Chairman of the Board, Chief Executive Officer
Qed Solutions, Inc
Online Software
11490 Commerce Park Dr, Herndon, VA 20191
(703) 821-3200
Victor V. Gogolak
Founder
Druglogic, Inc
Computer Related Services
11490 Commerce Park Dr, Herndon, VA 20191
(703) 821-3200, (703) 860-7081

Publications

Us Patents

Method And System For Web-Based Analysis Of Drug Adverse Effects

View page
US Patent:
6789091, Sep 7, 2004
Filed:
May 2, 2001
Appl. No.:
09/681583
Inventors:
Victor Gogolak - McLean VA, 22101
International Classification:
G06F 1700
US Classification:
7071041, 707 1
Abstract:
A computer-implemented method for accessing and analyzing the adverse effects resulting from the use of at least one drug of interest. The method includes storing data regarding the risks of adverse effects from the use of at least one drug of interest in one or more servers linked to the Internet. This data is updated with additional information pertinent to the risks of adverse effects from the use of the at least one drug of interest. A remote user is permitted to access the data through the World Wide Web upon proper authentication. The remote user is permitted to identify the at least one drug of interest and select data stored in one or more servers relevant to the safety of using the at least one drug of interest. The remote user is then permitted to analyze safety issues resulting from use of the at least one drug of interest and to display the requested data and any resulting analysis.

Method And System For The Analysis And Association Of Patient-Specific And Population-Based Genomic Data With Drug Safety Adverse Event Data

View page
US Patent:
7461006, Dec 2, 2008
Filed:
Aug 28, 2002
Appl. No.:
10/229119
Inventors:
Victor Gogolak - McLean VA, US
International Classification:
G06Q 10/00
US Classification:
705 2, 705 3, 707101, 7071041, 704233, 600300, 435 5
Abstract:
A method for assessing and analyzing one or more drugs, adverse effects and associated risks, and patient characteristics resulting from the use of at least drug of interest is disclosed. The method comprises the steps of selecting one or more cases for analysis, said cases describing the behavior between at least one drug of interest and a patient genotype; profiling statistically derived values from multiple cases related to the safety of the at least one drug, wherein at least one filter is employed for deriving said values; at least one data mining engine; and an output device for displaying the analytic results from the data mining engine. A system for performing the method is likewise disclosed.

Processing Drug Data

View page
US Patent:
7539684, May 26, 2009
Filed:
Feb 20, 2002
Appl. No.:
09/683828
Inventors:
Victor V. Gogolak - McLean VA, US
Lara Gogolak - McLean VA, US
Assignee:
QED Solutions, Inc. - McLean VA
International Classification:
G06F 17/30
US Classification:
707100, 704 9
Abstract:
Computer-assisted methods and systems of processing a drug information source. Characterizing the drug by the set comprising: syntax-parsed drug rule elements, adverse event data, mapped terms, and metadata. A method includes: creating a drug rule syntax; extracting metadata from the drug information source; extracting verbatim adverse event data from the drug information source; identifying drug rule content from the drug information source; mapping terms from verbatim data to a reference source; and parsing drug rule elements from at least one identified instance of drug rule content into the drug rule syntax, retaining associations between those drug rule elements that form a drug rule.

Method And System For Analyzing Drug Adverse Effects

View page
US Patent:
7542961, Jun 2, 2009
Filed:
May 2, 2001
Appl. No.:
09/681585
Inventors:
Victor Gogolak - McLean VA, US
International Classification:
G06F 15/18
G06F 15/00
A61K 49/00
G06F 7/00
G06F 17/30
US Classification:
706 62, 424 101, 707 3, 706924
Abstract:
The system of the present invention for assessing and analyzing the risks of adverse effects resulting from the use of at least one substance of interest, comprises a selector for identifying at least one substance of interest; a profiler for selecting from multiple profiles related to the safety of the at least one substance of interest, using at least one filter; at least one data mining engine; and an output device for displaying the analytic results from the data mining engine. Preferably, the at least one data mining engine is selected from (1) a proportional analysis engine to assess deviations in a set of the reactions to the drug of interest; (2) a comparator to measure the reactions to the drug of interest against a user-defined backdrop, and (3) a correlator to look for correlated signal characteristics in drug/reaction/demographic information; and an output device whereby a user can receive analytic results from the selector, the proportional analysis engine, the comparator, and the correlator.

Method For Graphically Depicting Drug Adverse Effect Risks

View page
US Patent:
7925612, Apr 12, 2011
Filed:
May 2, 2001
Appl. No.:
09/681586
Inventors:
Victor Gogolak - McLean VA, US
International Classification:
G06F 15/18
G06F 15/00
A61K 49/00
G06F 7/00
G06F 17/30
US Classification:
706 62, 424 101, 706924
Abstract:
An enhanced method for displaying assessment and analysis of risks of adverse effects resulting from use of at least one substance of interest, comprising: identifying the at least one substance of interest; selecting a profile related to the safety of the at least one substance of interest, using at least one filter; analyzing the risks of adverse effects resulting from the use of the at least one substance of interest using at least one data mining engine; and displaying the results of the analysis of risks of adverse effects in a format that permits perception of correlations. Such a format is preferably at least one format selected from the group consisting of a radar display for display of correlations, a sortable table, and a sortable line listing and where the format contains elements linked to data regarding the adverse effects.

Method And System For Analyzing Drug Adverse Effects

View page
US Patent:
7979373, Jul 12, 2011
Filed:
May 22, 2009
Appl. No.:
12/471034
Inventors:
Victor V. Gogolak - McLean VA, US
Assignee:
DrugLogic, Inc. - Reston VA
International Classification:
G06F 17/00
G06F 7/00
G06F 17/30
G06N 5/00
A61K 49/00
US Classification:
706 45, 707776, 424 101, 706924
Abstract:
A system for analyzing the risks of adverse effect resulting from the use of a drug comprises a selector for identifying at least one drug, a profiler for selecting from multiple profiles related to the safety of the drug, using at least one filter; at least one data mining engine; and an output device for displaying the analytic results from the data mining engine. Preferably, the at least one data mining engine is selected from (1) a proportional analysis engine to assess deviations in a set of reactions to the drug; (2) a comparator to measure the reactions to the drug against a user-defined backdrop, and (3) a correlator to look for correlated signal characteristics in drug/reaction/demographic information; and an output device whereby a user can receive analytic.

Processing Drug Data

View page
US Patent:
8131769, Mar 6, 2012
Filed:
May 14, 2009
Appl. No.:
12/466124
Inventors:
Victor V. Gogolak - McLean VA, US
Lara Gogolak - McLean VA, US
Assignee:
Druglogic, Inc. - McLean VA
International Classification:
G06F 7/00
G06F 17/30
US Classification:
707793, 704 9, 705 2
Abstract:
Computer-assisted methods and systems of processing a drug information source. Characterizing the drug by the set comprising: syntax-parsed drug rule elements, adverse event data, mapped terms, and metadata. A method includes: creating a drug rule syntax; extracting metadata from the drug information source; extracting verbatim adverse event data from the drug information source; identifying drug rule content from the drug information source; mapping terms from verbatim data to a reference source; and parsing drug rule elements from at least one identified instance of drug rule content into the drug rule syntax, retaining associations between those drug rule elements that form a drug rule.

Pharmacovigilance Database

View page
US Patent:
20020165853, Nov 7, 2002
Filed:
May 2, 2001
Appl. No.:
09/681587
Inventors:
Victor Gogolak - McLean VA, US
International Classification:
G06F007/00
US Classification:
707/003000
Abstract:
A system and method for developing a pharmacovigilance database from source data and reference data. The unedited source data contains verbatim terms. The method includes parsing source data into a relational safety database; performing cleanup on the relational safety database; and mapping verbatim terms from the cleaned safety database to at least one token from at least one reference source. Cleanup includes removing redundant entries, correcting misspellings, removing irrelevant non-alpha characters and noise words, and relocating dislocated terms. Mapping verbatim terms to tokens includes nominating tokens from the source data, choosing tokens from the reference sources, and linking chosen tokens to corresponding verbatim terms. In one embodiment, the history of clean-up and mapping is saved as the pedigree of the verbatim-to-token mapping.
Control profile
Victor V Gogolak from McLean, VA, age ~82 Get Report